HEADER ISOMERASE/IMMUNOSUPPRESSANT 06-APR-09 2WFJ TITLE ATOMIC RESOLUTION CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN TITLE 2 CYCLOPHILIN G IN COMPLEX WITH CYCLOSPORIN A. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE G; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PPIASE DOMAIN, RESIDUES 1-177; COMPND 5 SYNONYM: CYCLOPHILIN G, CLK-ASSOCIATING RS-CYCLOPHILIN, CASP10, COMPND 6 PEPTIDYL-PROLYL ISOMERASE G, PPIASE G, ROTAMASE G, CARS-CYCLOPHILIN, COMPND 7 CARS-CYP, SR-CYCLOPHILIN, SR-CYP, SRCYP; COMPND 8 EC: 5.2.1.8; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: CYCLOSPORIN A; COMPND 12 CHAIN: B; COMPND 13 SYNONYM: CYCLOSPORINE, CICLOSPORIN, CICLOSPORINE; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: ROSETTA (DE3) (NOVAGEN); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PETM-11; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM; SOURCE 12 ORGANISM_TAXID: 29910 KEYWDS ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, CYCLOPHILIN-CYCLOSPORIN COMPLEX, KEYWDS 2 CYCLOSPORIN A, IMMUNOSUPPRESSANT, CYCLOPHILIN EXPDTA X-RAY DIFFRACTION AUTHOR C.M.STEGMANN,G.M.SHELDRICK,M.C.WAHL REVDAT 4 22-MAY-19 2WFJ 1 REMARK LINK REVDAT 3 23-NOV-11 2WFJ 1 JRNL REVDAT 2 13-JUL-11 2WFJ 1 VERSN REVDAT 1 16-JUN-09 2WFJ 0 JRNL AUTH C.M.STEGMANN,D.SEELIGER,G.M.SHELDRICK,B.L.DE GROOT,M.C.WAHL JRNL TITL THE THERMODYNAMIC INFLUENCE OF TRAPPED WATER MOLECULES ON A JRNL TITL 2 PROTEIN-LIGAND INTERACTION. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 48 5207 2009 JRNL REFN ISSN 1433-7851 JRNL PMID 19499554 JRNL DOI 10.1002/ANIE.200900481 REMARK 2 REMARK 2 RESOLUTION. 0.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.112 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.111 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.129 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 10644 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 212742 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.103 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.102 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.121 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 8688 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 163760 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1428 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 6 REMARK 3 SOLVENT ATOMS : 298 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1660.6 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1253.3 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 20 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 16518 REMARK 3 NUMBER OF RESTRAINTS : 21007 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.016 REMARK 3 ANGLE DISTANCES (A) : 0.035 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.032 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.094 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.108 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.052 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.005 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.043 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.115 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2WFJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-APR-09. REMARK 100 THE DEPOSITION ID IS D_1290039413. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.6888 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : COLLIMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 212972 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.750 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 5.250 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.43 REMARK 200 R MERGE FOR SHELL (I) : 0.33000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.630 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIRECT METHODS REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: STRUCTURE WAS SOLVED BY APPLYING DIRECT METHODS IN SHELXD REMARK 200 IN TWO STAGES FIRST SEARCHING FOR 9 SULFUR ATOMS WITH THE HELP REMARK 200 OF PATTERSON SEEDING AND DUAL-SPACE DIRECT METHODS AND THEN REMARK 200 EXPANDING THE MOST PROMISING SOLUTIONS TO THE FULL STRUCTURE. REMARK 200 DATA WERE COLLECTED FROM A SINGLE CRYSTAL FIRST ON A BRUKER REMARK 200 ROTATING-ANODE GENERATOR, PRODUCING CUKALPHA RADIATION, AND A REMARK 200 SMART6000 16-MEGAPIXEL CCD TO A RESOLUTION OF 1.12A. DATA FROM REMARK 200 THE SAME CRYSTAL WERE THEN COLLECTED ON BEAMLINE PXII OF THE REMARK 200 SWISS LIGHT SOURCE (SLS, VILLIGEN, SWITZERLAND) USING A MAR CCD REMARK 200 225 DETECTOR AND MERGED WITH THE IN-HOUSE DATA. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28-32% (W/V) PEG 4000, 0.2M MGCL2, REMARK 280 0.1M TRIS PH 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 18.65950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.64250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.45650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.64250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 18.65950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.45650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 1120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 11 REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 CYCLIZATION IS ACHIEVED BY LINKING THE N- AND REMARK 400 THE C- TERMINI. REMARK 400 REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION REMARK 400 IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 ILE A 3 REMARK 465 LYS A 4 REMARK 465 VAL A 5 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 6 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 88 CB GLU A 88 CG -0.156 REMARK 500 GLU A 149 CD GLU A 149 OE1 0.071 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 9 NE - CZ - NH1 ANGL. DEV. = 7.8 DEGREES REMARK 500 ARG A 9 NE - CZ - NH2 ANGL. DEV. = -7.7 DEGREES REMARK 500 LYS A 52 CB - CG - CD ANGL. DEV. = 16.3 DEGREES REMARK 500 ARG A 85 NE - CZ - NH1 ANGL. DEV. = 4.3 DEGREES REMARK 500 GLU A 88 CA - CB - CG ANGL. DEV. = 13.8 DEGREES REMARK 500 GLU A 88 CG - CD - OE2 ANGL. DEV. = -12.2 DEGREES REMARK 500 GLU A 98 CB - CA - C ANGL. DEV. = -12.3 DEGREES REMARK 500 GLU A 98 N - CA - CB ANGL. DEV. = -10.9 DEGREES REMARK 500 LYS A 103 CD - CE - NZ ANGL. DEV. = 40.4 DEGREES REMARK 500 ARG A 115 NE - CZ - NH1 ANGL. DEV. = -5.3 DEGREES REMARK 500 ARG A 115 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 152 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ARG A 170 NE - CZ - NH2 ANGL. DEV. = 5.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 72 -78.01 -134.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2014 DISTANCE = 8.39 ANGSTROMS REMARK 525 HOH A2020 DISTANCE = 5.93 ANGSTROMS REMARK 525 HOH A2031 DISTANCE = 6.00 ANGSTROMS REMARK 525 HOH A2039 DISTANCE = 6.11 ANGSTROMS REMARK 525 HOH A2048 DISTANCE = 5.96 ANGSTROMS REMARK 525 HOH A2049 DISTANCE = 6.49 ANGSTROMS REMARK 525 HOH A2131 DISTANCE = 6.04 ANGSTROMS REMARK 525 HOH A2134 DISTANCE = 5.92 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 EDO A 1184 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1185 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A2207 O REMARK 620 2 HOH A2071 O 88.5 REMARK 620 3 HOH A2074 O 89.0 87.4 REMARK 620 4 HOH A2078 O 173.4 97.2 87.9 REMARK 620 5 HOH A2209 O 86.2 174.6 91.9 88.1 REMARK 620 6 HOH A2172 O 92.2 86.1 173.3 91.6 94.8 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1186 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A2103 O REMARK 620 2 HOH A2026 O 89.8 REMARK 620 3 HOH A2104 O 87.5 95.6 REMARK 620 4 HOH A2039 O 178.6 89.3 93.8 REMARK 620 5 HOH A2041 O 86.4 174.9 80.7 94.5 REMARK 620 6 HOH A2246 O 82.5 94.4 165.7 96.4 88.5 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1184 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1185 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1186 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1187 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF CYCLOSPORIN A REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2GW2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PEPTIDYL-PROLYL ISOMERASE DOMAINOF HUMAN REMARK 900 CYCLOPHILIN G REMARK 900 RELATED ID: 2WFI RELATED DB: PDB REMARK 900 ATOMIC RESOLUTION CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN REMARK 900 CYCLOPHILIN G REMARK 900 RELATED ID: 1BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 C REMARK 900 RELATED ID: 1C5F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CSA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1CWA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 1CWB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 1CWC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 D REMARK 900 RELATED ID: 1CWH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A MODIFIED AT POSITION 7 REMARK 900 RELATED ID: 1CWI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITION 7 REMARK 900 RELATED ID: 1CWJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH NODIFIED REMARK 900 CYCLOSPORIN C AT POSITIONS 1, AND 9 REMARK 900 RELATED ID: 1CYA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WIYH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYB RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1IKF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CTCLOSPORIN-FAB COMPLEX REMARK 900 RELATED ID: 1M63 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN COMPLEX REMARK 900 RELATED ID: 1MF8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN REMARK 900 CYCLOPHILIN AND CYCLOSPORIN A REMARK 900 RELATED ID: 1MIK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 6 REMARK 900 RELATED ID: 1QNG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED REMARK 900 WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1QNH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE REMARK 900 MUTANT) COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1XQ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2ESL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2OJU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2POY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II CYCLOPHILIN A REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2RMA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2RMB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 2RMC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2X2C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2X7K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2Z6W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3BO7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII REMARK 900 COMPLEXED WIT CYCLOSPORIN A REMARK 900 RELATED ID: 3CYS RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3EOV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI COMPLEXED REMARK 900 WITH CYCLOSPORIN A REMARK 999 REMARK 999 SEQUENCE REMARK 999 INITIAL GA RESIDUES ARE CLONING ARTEFACTS. DBREF 2WFJ A 1 177 UNP Q13427 PPIG_HUMAN 1 177 DBREF 2WFJ B 1 11 NOR NOR00033 NOR00033 1 11 SEQADV 2WFJ GLY A -1 UNP Q13427 EXPRESSION TAG SEQADV 2WFJ ALA A 0 UNP Q13427 EXPRESSION TAG SEQRES 1 A 179 GLY ALA MET GLY ILE LYS VAL GLN ARG PRO ARG CYS PHE SEQRES 2 A 179 PHE ASP ILE ALA ILE ASN ASN GLN PRO ALA GLY ARG VAL SEQRES 3 A 179 VAL PHE GLU LEU PHE SER ASP VAL CYS PRO LYS THR CYS SEQRES 4 A 179 GLU ASN PHE ARG CYS LEU CYS THR GLY GLU LYS GLY THR SEQRES 5 A 179 GLY LYS SER THR GLN LYS PRO LEU HIS TYR LYS SER CYS SEQRES 6 A 179 LEU PHE HIS ARG VAL VAL LYS ASP PHE MET VAL GLN GLY SEQRES 7 A 179 GLY ASP PHE SER GLU GLY ASN GLY ARG GLY GLY GLU SER SEQRES 8 A 179 ILE TYR GLY GLY PHE PHE GLU ASP GLU SER PHE ALA VAL SEQRES 9 A 179 LYS HIS ASN LYS GLU PHE LEU LEU SER MET ALA ASN ARG SEQRES 10 A 179 GLY LYS ASP THR ASN GLY SER GLN PHE PHE ILE THR THR SEQRES 11 A 179 LYS PRO THR PRO HIS LEU ASP GLY HIS HIS VAL VAL PHE SEQRES 12 A 179 GLY GLN VAL ILE SER GLY GLN GLU VAL VAL ARG GLU ILE SEQRES 13 A 179 GLU ASN GLN LYS THR ASP ALA ALA SER LYS PRO PHE ALA SEQRES 14 A 179 GLU VAL ARG ILE LEU SER CYS GLY GLU LEU SEQRES 1 B 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA MODRES 2WFJ MLE B 2 LEU N-METHYLLEUCINE MODRES 2WFJ MLE B 3 LEU N-METHYLLEUCINE MODRES 2WFJ MVA B 4 VAL N-METHYLVALINE MODRES 2WFJ BMT B 5 THR MODRES 2WFJ ABA B 6 ALA ALPHA-AMINOBUTYRIC ACID MODRES 2WFJ SAR B 7 GLY SARCOSINE MODRES 2WFJ MLE B 8 LEU N-METHYLLEUCINE MODRES 2WFJ MLE B 10 LEU N-METHYLLEUCINE HET DAL B 1 5 HET MLE B 2 9 HET MLE B 3 9 HET MVA B 4 8 HET BMT B 5 13 HET ABA B 6 6 HET SAR B 7 5 HET MLE B 8 9 HET MLE B 10 9 HET EDO A1184 3 HET MG A1185 1 HET MG A1186 1 HET CL A1187 1 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE HETNAM EDO 1,2-ETHANEDIOL HETNAM MG MAGNESIUM ION HETNAM CL CHLORIDE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 2 DAL C3 H7 N O2 FORMUL 2 MLE 4(C7 H15 N O2) FORMUL 2 MVA C6 H13 N O2 FORMUL 2 BMT C10 H19 N O3 FORMUL 2 ABA C4 H9 N O2 FORMUL 2 SAR C3 H7 N O2 FORMUL 3 EDO C2 H6 O2 FORMUL 4 MG 2(MG 2+) FORMUL 6 CL CL 1- FORMUL 7 HOH *298(H2 O) HELIX 1 1 CYS A 33 GLY A 46 1 14 HELIX 2 2 THR A 131 ASP A 135 5 5 HELIX 3 3 GLY A 147 ASN A 156 1 10 SHEET 1 AA 8 ARG A 67 VAL A 69 0 SHEET 2 AA 8 MET A 73 GLY A 76 -1 O MET A 73 N VAL A 69 SHEET 3 AA 8 PHE A 124 THR A 127 -1 O PHE A 124 N GLY A 76 SHEET 4 AA 8 LEU A 109 MET A 112 -1 O LEU A 109 N THR A 127 SHEET 5 AA 8 VAL A 140 SER A 146 -1 N PHE A 141 O LEU A 110 SHEET 6 AA 8 GLN A 19 LEU A 28 -1 O VAL A 25 N ILE A 145 SHEET 7 AA 8 ARG A 9 ILE A 16 -1 O CYS A 10 N PHE A 26 SHEET 8 AA 8 VAL A 169 GLU A 176 -1 O ARG A 170 N ALA A 15 LINK MG MG A1185 O HOH A2207 1555 4565 2.07 LINK MG MG A1185 O HOH A2071 1555 1555 2.08 LINK MG MG A1185 O HOH A2074 1555 1555 2.08 LINK MG MG A1185 O HOH A2078 1555 1555 2.07 LINK MG MG A1185 O HOH A2209 1555 4565 2.05 LINK MG MG A1185 O HOH A2172 1555 4565 2.07 LINK MG MG A1186 O HOH A2103 1555 1555 2.08 LINK MG MG A1186 O HOH A2026 1555 2674 2.41 LINK MG MG A1186 O HOH A2104 1555 1555 2.04 LINK MG MG A1186 O HOH A2039 1555 1555 1.94 LINK MG MG A1186 O HOH A2041 1555 1555 2.00 LINK MG MG A1186 O HOH A2246 1555 2674 2.03 LINK N DAL B 1 C ALA B 11 1555 1555 1.33 LINK C DAL B 1 N MLE B 2 1555 1555 1.36 LINK C MLE B 2 N MLE B 3 1555 1555 1.35 LINK C MLE B 3 N MVA B 4 1555 1555 1.34 LINK C MVA B 4 N BMT B 5 1555 1555 1.35 LINK C BMT B 5 N ABA B 6 1555 1555 1.35 LINK C ABA B 6 N SAR B 7 1555 1555 1.35 LINK C SAR B 7 N MLE B 8 1555 1555 1.32 LINK C MLE B 8 N VAL B 9 1555 1555 1.32 LINK C VAL B 9 N MLE B 10 1555 1555 1.34 LINK C MLE B 10 N ALA B 11 1555 1555 1.37 SITE 1 AC1 6 LYS A 48 ILE A 90 TYR A 91 SER A 99 SITE 2 AC1 6 HOH A2060 HOH A2180 SITE 1 AC2 6 HOH A2071 HOH A2074 HOH A2078 HOH A2172 SITE 2 AC2 6 HOH A2207 HOH A2209 SITE 1 AC3 6 HOH A2026 HOH A2039 HOH A2041 HOH A2103 SITE 2 AC3 6 HOH A2104 HOH A2246 SITE 1 AC4 5 GLY A 86 ARG A 115 GLY A 121 SER A 122 SITE 2 AC4 5 GLN A 123 SITE 1 AC5 23 THR A 45 GLY A 46 GLU A 47 GLY A 49 SITE 2 AC5 23 THR A 50 ARG A 67 PHE A 72 GLN A 75 SITE 3 AC5 23 GLY A 84 ALA A 113 ASN A 114 ARG A 115 SITE 4 AC5 23 GLN A 123 PHE A 125 HIS A 133 HIS A 138 SITE 5 AC5 23 HOH A2136 HOH B2001 HOH B2003 HOH B2006 SITE 6 AC5 23 HOH B2007 HOH B2008 HOH B2009 CRYST1 37.319 64.913 69.285 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026796 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015405 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014433 0.00000